A

Avance Clinical Trials | Laguna Niguel, CA

Research site
(Unclaimed)
Location
27021 Alicia Parkway, Suite G, Laguna Niguel, California, United States of America
Site insights

Top conditions

Atopic Dermatitis (3 trials)

Dermatitis (3 trials)

Eczema (3 trials)

Psoriasis (2 trials)

Chronic Urticaria (1 trial)

Top treatments

Apremilast
Lebrikizumab
AMG 451
CC-10004
Dupilumab
Rocatinlimab

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

4 of 6
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Study of (LY3650150) Lebrikizumab to Assess the Safety and Efficacy of Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis and Skin of Color (ADmirable)

The main purpose of this study is to determine the safety and efficacy lebrikizumab in adolescent and adult participants with moderate-to-severe atop...

Enrolling
Atopic Dermatitis
Drug: Lebrikizumab
Locations recently updated

The primary objective of this post-marketing study is to assess the safety and tolerability of apremilast in pediatric participants (ages 6 through 1...

Enrolling
Plaque Psoriasis
Drug: Apremilast

The study will assess the safety and efficacy of lebrikizumab in adult and adolescent participants with moderate-to-severe atopic dermatitis (AD) pre...

Active, not recruiting
Atopic Dermatitis
Drug: Lebrikizumab

The purpose of this study is to evaluate the efficacy and safety of rocatinlimab in monotherapy and combination therapy treatment in adolescent subje...

Enrolling
Atopic Dermatitis
Drug: Placebo
Drug: Rocatinlimab

Trial sponsors

Amgen logo

Amgen (4 trials)

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems